Tolerance to the sedative effect of lorazepam correlates with a diminution in cortical release and affinity for glutamate
The DOI matches its Crossref record; 31 of the 33 references it cites were found in a registry or an index.
Abstract
Benzodiazepines are anxiolytic, anticonvulsant, sedative and hypnotic compounds usually prescribed on a long-term basis. Chronic treatment with these compounds induces tolerance, which has been extensively attributed to modifications in the GABAergic neurotransmission. However, a compensatory increase in the excitatory response, named as an oppositional response, has also been put forward as a means for explaining such tolerance. Changes in the excitatory neurotransmission have been found in withdrawn rats after a long treatment with benzodiazepines but these modifications have not been conclusively studied during tolerance. In this work we studied several parameters of the glutamatergic neurotransmission in rats made tolerant to the sedative effect of 3 mg/kg (i.p.) of lorazepam (LZ). We found a decrease in the affinity of cortical NMDA receptors for (3)H-glutamate (K(D): 124.4 +/- 13.3 nM in tolerant rats, 71.6 +/- 10.4 nM in controls, P<0.05) together with a decrease in the in vitro 60 mM K(+)-stimulated cortical glutamate release (59+/- 12% vs. 153 +/- 38%, tolerant rats vs. controls, P<0.05). We conclude that tolerance to the sedative effect of LZ correlates with a decreased sensitivity for glutamate that may in turn diminish the cortical response to a chemical stimulus. Our findings constitute an evidence against the oppositional model of pharmacodynamic tolerance in this experimental condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“tolerance to the sedative effects of lorazepam after 21-day treatment correlated with a decreased rather than an increased sensitivity for glutamate (using[(3)H] glutamate binding) [129].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [129]
Citations
Cites
Subunit- and site-specific pharmacology of the NMDA receptor channel
Yamakura, T., & Shimoji, K. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00007-6 · Cited by 311
Miller, L. G., Greenblatt, D. J., Barnhill, J. G., & Shader, R. I. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20998-3 · Cited by 220
Ethanol tolerance and synaptic plasticity
Chandler, L. J., Harris, R. A., & Crews, F. T. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01268-1 · Cited by 154
Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding
Rosenberg, H. C., & Chiu, T. H. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90356-3 · Cited by 135
Autoradiographic localization of benzodiazepine receptor downregulation.
Tietz, E. I., Rosenberg, H. C., & Chiu, T. H. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38798-7 · Cited by 114
Izzo, E., Auta, J., Impagnatiello, F., Pesold, C., Guidotti, A., & Costa, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051628698 · Cited by 90
Current concepts of ethanol dependence
LITTLETON, J., & LITTLE, H. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03736.x · Cited by 79
Tolerance to diazepam and changes in GABAA receptor subunit expression in rat neocortical areas
Pesold, C., Caruncho, H. J., Impagnatiello, F., Berg, M. J., Fritschy, J., Guidotti, A., & Costa, E. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00609-4 · Cited by 77
A glutamatergic hypothesis of drug dependence: extrapolations from benzodiazepine receptor ligands
Stephens, D. N. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199508000-00004 · Cited by 68
Chen, S., Huang, X., Zeng, X. J., Sieghart, W., & Tietz, E. I. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00118-9 · Cited by 66
Cited by
Towards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
“…investigating the effect of chronic (21 days) treatment with lorazepam found that, while glutamate release from prefrontal cortex slices in superfusion was reduced, in hippocampus the same treatment resulted in a marked and significant increase of glutamate release (Bonavita et al., 2002, 2003).”
BackgroundVinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
“Moreover, a straightforward glutamate sensitization may be an oversimplification, as tolerance to the sedative effects of lorazepam after 21-day treatment correlated with a decreased rather than an increased sensitivity for glutamate (using glutamate binding) [129].”
BackgroundKeefe, J. R., Mao, J. J., Soeller, I., Li, Q. S., & Amsterdam, J. D. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.10.013 · Cited by 102
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript 2005; Bateson, 2002; Biggio et al., 2003; Bonavita et al., 2002).”
BackgroundFerrero, A. J., Cereseto, M., Reinés, A., Bonavita, C. D., Sifonios, L. L., Rubio, M. C., & Wikinski, S. I. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.013 · Cited by 42
Self-citationAmsterdam, J. D., Williams, D., Michelson, D., Adler, L. A., Dunner, D. L., Nierenberg, A. A., Reimherr, F. W., & Schatzberg, A. F. (2009) · Neuropsychobiology · doi:10.1159/000226611 · Cited by 39
Metadata
- Authors
- Bonavita, C. D., Bisagno, V., Bonelli, C. G., Acosta, G. B., Rubio, M. C., & Wikinski, S. I.
- Affiliations
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Corresponding author
- Bonavita, C.D.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 42
- Issue
- 5
- Pages
- 619-625
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2077885190
- Cited by
- 19
- References
- 33
- Citations by year
- 2026: 1 · 2022: 1 · 2017: 1 · 2016: 2 · 2015: 1 · 2013: 1 · 2012: 1
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Consejo Nacional de Investigaciones Científicas y Técnicas
- Agencia Nacional de Promoción Científica y Tecnológica
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- lorazepam, benzodiazepine tolerance, sedative effects, glutamatergic neurotransmission, GABAergic neurotransmission
- MeSH terms
- Animals, Binding Sites, Cerebral Cortex, Dose-Response Relationship, Drug, Drug Tolerance, Hypnotics and Sedatives, Lorazepam, Male, Motor Activity, Receptors, N-Methyl-D-Aspartate, Rats, Wistar, Glutamic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tolerance to the sedative effect of lorazepam correlates with a diminution in cortical release and affinity for glutamate. https://app.cochat.ai/papers/10.1016/s0028-3908(02)00012-6
- The paper
- Bonavita, C. D., Bisagno, V., Bonelli, C. G., Acosta, G. B., Rubio, M. C., & Wikinski, S. I. (2002). Tolerance to the sedative effect of lorazepam correlates with a diminution in cortical release and affinity for glutamate. Neuropharmacology. https://doi.org/10.1016/s0028-3908(02)00012-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.